Insider · CIK 0001639935
Nicholas Lydon
Files at: ANAB, BPMC. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2018 SForm 4 → | Apr 18, 4:46 pm EDT | ANAPTYSBIO INCANAB | 33,000 | $86.88 | $2,866,913 | 271,106 | −10.9% | plan? |
| Feb 28, 2018 SForm 4 → | Mar 2, 5:15 pm EST | Blueprint Medicines CorpBPMC | 25,000 | $87.89 | $2,197,356 | 177,727 | −12.3% | plan? |
| Feb 15, 2018 MForm 4 → | Feb 20, 4:08 pm EST | ANAPTYSBIO INCANAB | 16,483 | $4.55 | $74,998 | 304,106 | — | plan? |
| Mar 14, 2017 SForm 4 → | Mar 16, 5:37 pm EDT | Blueprint Medicines CorpBPMC | 70,000 | $40.05 | $2,803,724 | 202,727 | −25.7% | plan? |
| Jan 31, 2017 PForm 4 → | Jan 31, 4:49 pm EST | ANAPTYSBIO INCANAB | 16,666 | $15.00 | $249,990 | 287,623 | +6.15% | plan? |
| Jan 31, 2017 CForm 4 → | Jan 31, 4:49 pm EST | ANAPTYSBIO INCANAB | 203,625 | — | — | 270,957 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2019 AForm 4 → | Feb 11, 5:31 pm EST | ANAPTYSBIO INCANAB | 6,000 | — | — | 6,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:56 pm EDT | Blueprint Medicines CorpBPMC | 7,500 | — | — | 29,318 | — | |
| Feb 15, 2018 MForm 4 → | Feb 20, 4:08 pm EST | ANAPTYSBIO INCANAB | 16,483 | — | — | 0 | — | |
| Feb 2, 2018 AForm 4 → | Feb 6, 4:11 pm EST | ANAPTYSBIO INCANAB | 6,000 | — | — | 6,000 | — | |
| Jun 21, 2017 AForm 4 → | Jun 23, 4:25 pm EDT | Blueprint Medicines CorpBPMC | 10,909 | — | — | 21,818 | — | |
| Feb 24, 2017 AForm 4 → | Feb 28, 6:54 pm EST | ANAPTYSBIO INCANAB | 15,000 | — | — | 15,000 | — | |
| Jan 31, 2017 CForm 4 → | Jan 31, 4:49 pm EST | ANAPTYSBIO INCANAB | 203,625 | — | — | 0 | — | |
| Jun 23, 2016 AForm 4 → | Jun 27, 4:24 pm EDT | Blueprint Medicines CorpBPMC | 10,909 | — | — | 10,909 | — |